Back to search results

Allogeneic PB103 (NK Cells) Therapy in Non-small Cell Lung Cancer (NSCLC) Patients

Abroad (travel likely)RecruitingPHASE1, PHASE2

Conditions

Non-small Cell Lung Cancer

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations
Study leads

  • Ming-Shen Dai, MD/PhD

    Principal Investigator

    Tri-Service General Hospital

View source on ClinicalTrials.gov(opens in a new tab)Contact study team (email)